PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, United States.\', \'National Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD, United States.\', \'National Institute of Neurological Diseases and Strokes, National Institutes of Health (NIH), Bethesda, MD, United States.\', \'Undiagnosed Disease Program, National Institutes of Health (NIH), Bethesda, MD, United States.\', \'National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD, United States.\', \'National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD, United States.\', \'Department of Laboratory Medicine, Clinical Center, National Institutes of Health (NIH), Bethesda, MD, United States.\', \'National Institute of Digestive Diseases and Kidney Diseases, National Institutes of Health (NIH), Bethesda, MD, United States.\', \'National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH), Bethesda, MD, United States.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.811473
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 35095905
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • The Spectrum of the Deficiency of Adenosine Deaminase 2: An Observational Analysis of a 60 Patient Cohort.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all